Treatment Guidelines -including when to start

Aging, HIV and the possible effect of nukes

published: April, 08, 2013 Written by // Kinder, gentler, more understanding. Categories // Aging, As Prevention , CATIE, Treatment Guidelines -including when to start, Newly Diagnosed, CATIE - HIV and Hep C Info Resource, Health, Treatment, Living with HIV, Population Specific

How safe are HIV drugs and when to start treatment? CATIE’s Sean Hosein reviews the impact of nukes (nucleoside reverse transcriptase inhibitor) on our bodies, including whether they contribute to premature aging – and how.. . .

Aging, HIV and the possible effect of nukes

This article by Sean Hosein first appeared on the CATIE website here   Une version française est disponible ici.  In high-income countries such as Canada, Australia and the U.S. and in regions such as Western Europe, huge advances have been made in the treatment of HIV disease. Researchers increasingly expect that a young person who is diagnosed today and who initiates potent combination anti-HIV therapy (commonly called ART or HAART) and who has minimal co-existing health conditions sho

The HIV treatment cascade – patching the leaks to improve HIV prevention

published: March, 07, 2013 Written by // CATIE - HIV and Hep C Info Resource Categories // As Prevention , CATIE, Treatment Guidelines -including when to start, Newly Diagnosed, Research, Sexual Health, CATIE - HIV and Hep C Info Resource, Health, Treatment, Living with HIV, Population Specific

CATIE on the concept of a treatment cascade that's a way to identify gaps in the testing-care-treatment continuum, which are preventing people from realizing the treatment and prevention benefits of antiretroviral therapy.

The HIV treatment cascade – patching the leaks to improve HIV prevention

This article by CATIE’s James Wilton and Logan Broeckaert first appeared on the CATIE  website here. Une version française est disponible ici. We have known for years that antiretroviral therapy can significantly improve the health outcomes of people living with HIV. More recently, research has revealed the important role that antiretroviral therapy plays in preventing the transmission of the virus. As HIV treatment and prevention have converged, attention has turned to how well we are e

HIV Testing - Part One

published: February, 28, 2013 Categories // Treatment Guidelines -including when to start, Health, Sexual Health, International , Treatment, Opinion Pieces

New writer, Scotland’s Roy Kilpatrick on why testing has become an even more integral part of HIV prevention than ever, how we tailor testing strategies, why they sometimes fall short and what we must do next.

HIV Testing - Part One

Testing has become one of the most prominent of HIV messages. Its centrality to HIV prevention is strengthened by all the benefits of treatment, and the earlier the better.  To reduce current levels of late and very late diagnosis currently recorded, early recognition and detection are essential.  The rationale for promotion of testing cannot be flawed. Testing for HIV is integral to tackling HIV at both population and at individual levels. A key question, however, touches upon balance in

Treatment on diagnosis may be needed, say researchers

published: February, 14, 2013 Written by // Guest Authors - Revolving Door Categories // Gay Men, As Prevention , Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Guest Authors, Living with HIV, Population Specific

Aidsmap.com reports HIV incidence in gay men unchanged in England and Wales, despite more testing

Treatment on diagnosis may be needed, say researchers

This article by Gus Cairns first appeared on aidsmap.com here.   A paper in The Lancet Infectious Diseases by scientists from the UK’s Medical Research Council and the Health Protection Agency (HPA) has calculated that the number of gay men in England and Wales who become infected with HIV each year remained unchanged between 2001 and 2010. This is despite a considerable increase in testing and, they estimate, a 40% reduction in the proportion of gay men with HIV who are undiagnosed. The

Why it is important to have HIV treatment guidelines

published: December, 16, 2012 Written by // Guest Authors - Revolving Door Categories // Treatment Guidelines -including when to start, Newly Diagnosed, Research, Health, Revolving Door, International , Treatment, Guest Authors, Living with HIV, Population Specific

Canada doesn’t have its own treatment guidelines, so there are no recommended standard treatments or start dates. Is this good? Aidsmap.com details Swiss research which identifies factors associated with the use of non-recommended HIV therapy

Why it is important to have HIV treatment guidelines

This article by Michael Carter first appeared on aidsmap.com here.  New Swiss research shows the importance of observing antiretroviral treatment guidelines, even in people who have well-controlled HIV infection. Published in the online edition of the Journal of Acquired Immune Deficiency Syndromes, the study demonstrated that toxicities and concerns about long-term side-effects were common reasons for switching to recommended treatment. CD4 cell count, viral load and adherence either remain

Starting Treatment Early

published: August, 26, 2012 Written by // Guest Authors - Revolving Door Categories // As Prevention , Treatment Guidelines -including when to start, Research, Health, Revolving Door, Treatment, Guest Authors, Living with HIV

Three-quarters of clinicians in the US willing to prescribe early HIV treatment for the purpose of prevention, reports aidsmap

Starting Treatment Early

This article by Michael Carter first appeared on NAM/aidsmap.  Republished with permission.  There is an overwhelming consensus among clinicians who prescribe HIV treatment in the US that people who are taking antiretroviral therapy are less likely to transmit HIV to their sexual partners, according to results of a study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Results also showed that over three-quarters of care providers would be willing to

When to start treatment?

published: April, 03, 2012 Written by // Bob Leahy - Publisher Categories // Current Affairs, Treatment Guidelines -including when to start, Health, Treatment, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

New US guidelines released just last week recommend treatment for all people with HIV infection. Are they a step in the right direction, something that others should consider following? Bob Leahy reports.

When to start treatment?

Newly updated US treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, rather than starting at a particular CD4 range. But for those about to start treatment and their doctors, it’s not quite that simple; the strength of the recommendations varies by category of patient. Here is how a simplified scale looks: CD4 count less than 350 – strong recommendation CD4 count 350 to 500 - strong recommendation CD4 count over 500 – moderate recommend

RX Coles Notes: Starting Treatment Early – emerging results

published: December, 16, 2011 Written by // Brian Finch - Founder Categories // Treatment Guidelines -including when to start, Research, Revolving Door, Treatment

People starting treatment early fared better in this study.

 RX Coles Notes: Starting Treatment Early – emerging results

A recent study, published in MedPage Today, conducted at the Medical College of Wisconsin in Milwauke, demonstrated that people with early HIV infection initiating treatment right away did much better than those who waited to begin, based on present day treatment guidelines. Present day guidelines as to when to begin treatment are usually based on the T4 cell count. Traditional guidelines say that a T4 (CD4) count of 200 or below is when to start. As of a year and a half ago the Int

When to start HIV Treatment? New study suggests early isn’t better.

published: November, 07, 2011 Categories // Treatment Guidelines -including when to start, Health, Revolving Door, Treatment

Cohort Study: No AIDS-Free Survival Benefit to Starting HIV Treatment at CD4s of 500 or More

When to start HIV Treatment?  New study suggests early isn’t better.

  This article first appeared in unedited form in AIDSMeds October 11, 2011 Starting antiretroviral (ARV) therapy with a CD4 count above 500 doesn’t decrease the risk of AIDS or death from any cause—at least over an average follow-up period that approached five years—according to a new report from a large cohort study published in the September 26 issue of Archives of Internal Medicine. For people living with HIV with CD4s below 350, the Concerted Action on SeroConversion to AIDS and

The World Health Organization delivers new HIV prevention and treatment guidelines

published: August, 24, 2011 Categories // As Prevention , Treatment Guidelines -including when to start, Health, Treatment

Devan Nambiar unravels the WHO’s latest global recommendations on services for MSM and transgendered people

The World Health Organization (WHO) has issued comprehensive recommendations on the prevention and treatment of HIV and sexually transmitted infections among men who have sex with men (MSM) and transgendered people. The guidance emphasizes the very high vulnerability of MSM and transgender people to HIV infection, even in settings where the majority of HIVinfections occur through sex between men and women. In the last 5 years we have seen an increase in HIV infections in MSM across Canada

New 2011 HIV Treatment Guidelines

published: January, 31, 2011 Categories // Treatment Guidelines -including when to start, Health, Treatment

Devan Nambiar looks at recent changes in standards of care for people living with HIV

The US Dept. of Health and Humans Services updated the HIV treatment guidelines in January 2011. The review and clinical updates is conducted twice a year as science understands more of the intricacies of HART and the immune health. What has changed? 1. The guidelines state that CD4 + cells /mm3 only need to be monitored every 6 to 12 months for most HIV positive persons who are successful on HART and does not have another concomitant illness. Concomitant illness such as kidney disease, liver

<<  12 13 14 15 16 [17